SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis
| Autor: | Weinrauch, Larry A., Liu, Jiankang, Segal, Alissa R., Woodward, Jason, D'Elia, John A. |
|---|---|
| Zdroj: | In Journal of Diabetes and Its Complications February 2021 35(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect